The treatment regimen of multi drug resistant TB consists of usually four months of seven drugs (bedaquiline, levofloxacin, clofazimine, is...

On September 21, several stocks made notable moves by crossing their 50-day SMA, indicating potential positive developments.

ICICI PRU SMALL CAP: Under the new mandate, the fund has a portfolio balanced between quality compounders and normalcy candidates on the pa...

The data were gathered from a panel of 9,000 stockists who store products from approximately 5,000 pharmaceutical companies.

A total of 2800 units of 3 bedrooms and 3 toilets, and, 1200 units of 2 bedrooms and 2 toilets will be constructed under the two projects.

The action was seen in select small & midcap names as consolidation in several sectors has benefited select companies who have used the Pan...

Pharma and PSU bank stocks saw good buying interest while private bank scrips were under selling pressure.

Volatility indicator India VIX surged significantly during the session.

While the frontline stocks were upbeat, the real action was in mid and small cap stocks which outperformed as investors hunted for value.

The annual sales value of these medicines has shrunk from nearly Rs 3,000 crore in 2016 to Rs 2,183 crore now.

The $32-bn generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises.

Bans test the limits of our regulatory frameworks. 2016 had its fair share of bans. Here are the top five.

Citigroup sees limited scope for further deterioration in Cadilla Healthcare financials.

With foreign institutional investors (FIIs) shying away from taking long bets in the Indian markets, the picture does not look very attract...

"We like consumption, but valuations are still not so attractive."

FDA said that their several products have been found to be "adulterated" under relevant regulations and did not carry the required permits ...

'The trial for a drug Rifaximin took place at Kota, Jaipur & Mumbai. “Kota and Jaipur can hardly be classified cosmopolitan in demography '...